Stay updated on AK102 in HeFH: PCSK9 Inhibitor Clinical Trial

Sign up to get notified when there's something new on the AK102 in HeFH: PCSK9 Inhibitor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK102 in HeFH: PCSK9 Inhibitor Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated by one patch level (v3.5.2 → v3.5.3), with no accompanying changes shown to the clinical trial’s record history entries.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:19.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A new revision v3.5.2 is added to the study record history. The revision v3.5.0 is removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:12:33.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0 on the page. The previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T22:53:13.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new revision (v3.4.3) appears in the study record history, replacing v3.4.2. This is a minor update to the page without changing study data.
    Difference
    0.2%
    Check dated 2026-03-11T19:57:52.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Recruitment Status in the study record was updated in version 2.
    Difference
    0.1%
    Check dated 2026-03-04T15:44:50.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; older notices about funding lapse and operating status were removed.
    Difference
    0.9%
    Check dated 2026-02-11T09:26:59.000Z thumbnail image

Stay in the know with updates to AK102 in HeFH: PCSK9 Inhibitor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK102 in HeFH: PCSK9 Inhibitor Clinical Trial page.